Pancreatic cancer is a devastating disease, with a death rate close to the incidence rate.  Because more than 90% of pancreatic cancer cases are diagnosed at the metastatic stage, when there are only limited therapeutic options, earlier diagnosis is anticipated to have a major impact on extending life expectancy for patients. However, there has been a lack of reliable markers, early indicators and risk factors … Continue reading Early indicators of pancreatic cancer identified in precision medicine study.